Advertising of Prescription Drugs
- 4 August 1988
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 319 (5) , 314-315
- https://doi.org/10.1056/nejm198808043190522
Abstract
To the Editor: Cohen (Feb. 11 issue)1 opposes direct-to-consumer prescription-drug ads, referring negatively to our earlier work.2 Our position is unchanged. Prices are likely to fall; statistical analyses in other industries show that ads lower consumer prices. Also, a decision to prescribe may be improved when an ad prompts a patient to volunteer information about himself or herself to the physician — information that might otherwise never be considered. An example: A man taking an antihypertensive drug experiences impotence and discontinues treatment without telling his physician. After seeing an ad for a product free of the side effect, the man . . .Keywords
This publication has 8 references indexed in Scilit:
- Direct-to the-Public Advertisement of Prescription DrugsNew England Journal of Medicine, 1988
- Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1988
- A Ban on the Promotion of Tobacco ProductsNew England Journal of Medicine, 1987
- Matching Prescription Drugs and ConsumersNew England Journal of Medicine, 1985
- Drug promotion: FDA steps inNature, 1982
- Health and Medicine on TelevisionNew England Journal of Medicine, 1981
- The Effect of Advertising on the Price of EyeglassesThe Journal of Law and Economics, 1972
- The Saga of ThalidomideNew England Journal of Medicine, 1962